A: Because it stimulates your bodys natural pathways rather than shutting them down with synthetic hormones, long-term risks are considered low for healthy individuals
Your first appointment will take a little longer as we show you around and talk you through the process
A separate Phase 2 trial also published in The New England Journal of Medicine in 2023 evaluated retatrutide in adults with type 2 diabetes, reporting meaningful reductions in HbA1c alongside weight loss, with hypoglycaemia rates that were low in the absence of insulin or sulfonylurea co-administration
Oxid Med Cell Longev 2018;2018:9719584 Reynaert NL, Gopal P, Rutten EPA, Wouters EFM, Schalkwijk CG
This philosophy extends across our entire catalog, from foundational research compounds like BPC-157 to more complex formulations like our Wolverine Peptide Stack